Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

24-Aug-17 - 22-Aug-18
Buy Ratio:33%


# Net Buyers:103
# Net Sellers:208

Previous 52 Weeks

25-Aug-16 - 23-Aug-17
Buy Ratio:41%
# Net Buyers:137
# Net Sellers:199
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Mylan N.V.($18.48M)$1.81B  
Catalent, Inc.($17.77M)$396.57M  
Bausch Health Companies Inc.($650.58K)$231.26M  
Seattle Genetics Inc /wa$246.07M$130.70M  
Intrexon Corp$138.50M$125.02M  
New Net Buyers
CompanyNet Buy AmountChange
Portola Pharmaceuticals Inc$5.74M$102.53M  
Acceleron Pharma Inc$16.30M$74.93M  
Corcept Therapeutics Inc$1.98M$66.42M  
Esperion Therapeutics, Inc.$16.26M$65.52M  
Akorn Inc$40.72M$43.99M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Juno Therapeutics, Inc.($1.28B)($1.06B)  
Colucid Pharmaceuticals, Inc.--($714.41M)  
Kite Pharma, Inc.($675.84M)($605.08M)  
Loxo Oncology, Inc.($430.95M)($426.93M)  
Lilly Eli & Co($358.70M)($229.50M)  
New Net Sellers
CompanyNet Buy AmountChange
Alexion Pharmaceuticals, Inc.($6.35M)($218.55M)  
Madrigal Pharmaceuticals, Inc.($139.35M)($139.49M)  
Alnylam Pharmaceuticals, Inc.($94.97M)($107.81M)  
Agios Pharmaceuticals Inc($45.75M)($46.40M)  
Collegium Pharmaceutical, Inc($26.79M)($26.84M)